India Plasma Fractionation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

India Plasma Fractionation Market Analysis

The India Plasma Fractionation Market size is estimated at USD 1.66 billion in 2024, and is expected to reach USD 2.26 billion by 2029, growing at a CAGR of 6.39% during the forecast period (2024-2029).

Factors such as the growing use of immunoglobulins in various therapeutic areas, the rising geriatric population, and the rising prevalence of rare diseases are expected to drive market growth in India. For instance, according to the report published by Observer Research Foundation in July 2022, a higher prevalence of β-thalassemia was observed in pockets of Gujarat, Punjab, West Bengal, Odisha, and Andhra Pradesh than in the rest of the country. Mostly, patients with β-thalassemia major are advised to take leucoreduced packed red blood cells with a minimum hemoglobin content of 40 grams. Thus, due to the utilization of plasma cells for treating rare diseases like thalassemia, the demand in the market is expected to witness significant growth during the forecast period. Moreover, investments by key companies in India to develop plasma products are expected to create a demand for them. For instance, in September 2022, Reliance Life Sciences invested up to INR 2,500 crore (USD 0.3 million) to develop novel vaccines and gene therapies in the new facility in Nashik. The company plans to produce complicated monoclonal antibodies, plasma proteins, and biosimilar products to treat patients in critical care.

Also, an increase in the geriatric population in India is another reason for the market growth during the forecast period. Also, the most common causes of hypoalbuminemia include liver disease, heart failure, malnutrition, or vitamin deficiency. Malnutrition is a highly prevalent condition among the geriatric population, and proper nutritional intake is required to be healthy. According to the India Ageing Report 2023, India's aging population is increasing at a moderate pace. Projections showed that the proportion of elderly individuals in South Asia will reach 20% by 2022 and 36.1% by 2050. The geriatric population in India is expected to utilize plasma products, driving market growth during the forecast period.

Thus, owing to the increase in investment and government initiatives to support plasma fractionation and the rise in strategic activities by the key players, the market is expected to witness notable growth in India during the forecast period. However, the high cost of blood plasma products is expected to hinder market growth during the forecast period.

India Plasma Fractionation Market Trends

The Platelets and Coagulation Factor Concentrates Segment is Expected to Witness a Positive Growth Over the Forecast Period

India Plasma Fractionation Industry Segmentation

As per the scope of the report, plasma fractionation is defined as the general process of separating the various components of blood plasma obtained via blood fractionation. Plasma contains multiple proteins, including immunoglobulins, albumin, and coagulation proteins.

The Indian plasma fractionation market is segmented by product, application, and end user. By product, the market is segmented into immunoglobulins, platelets and coagulation factor concentrates, albumin, and other products. By application, the market is segmented into neurology, immunology, hematology, and other applications. By end user, the market is segmented into hospitals and clinics, clinical research laboratories, and other end users. The other end users include academia and research institutes. The report offers market size and forecasts in value (USD) for the above segments.